FMO5 and cancer: As a result, Ets-1 accumulates in cancer cells and the increase in Ets-1 results in higher Ets-1 transcriptional activity, which may then stimulate ROS production by promoting NADPH oxidase complex activity, both directly and indirectly, particularly by increasing the expression of stromelysin-1 (Fig. 8B).